Telemetry Investments’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Telemetry Investments’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,700	Closed	-$251K	–	212
2021 Q4	$251K	Buy	+2,700	New	+$178K	0.32%	104
2015 Q3	–	Sell	-11,000	Closed	-$510K	–	177
2015 Q2	$510K	Buy	+11,000	New	+$477K	0.23%	75

Telemetry Investments's ARNA Position: Q1 2022 in Review

Telemetry Investments sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 2,700 shares — an estimated $251K sold.

Telemetry Investments first reported a position in ARNA in Q2 2015 and held it in 2 quarters. The position peaked at $510K in Q2 2015. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Telemetry Investments reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Telemetry Investments sold 2,700 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $251K.
Telemetry Investments first reported a position in Arena Pharmaceuticals Inc in Q2 2015 and held it in 2 quarters.
Telemetry Investments's Arena Pharmaceuticals Inc position peaked at $510K in Q2 2015.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Telemetry Investments's 13F filing for Q1 2022, filed 16 May 2022.